Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2012
08/30/2012US20120220571 Hiv integrase inhibitors
08/30/2012US20120220569 Fused heterocyclic ring derivative and use thereof
08/30/2012US20120220566 Antimicrobial Compounds and Methods of Making and Using the Same
08/30/2012US20120220561 Oxadiazole inhibitors of leukotriene production
08/30/2012US20120219593 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
08/30/2012US20120219495 Novel tetraaza macrocyclic compound, preparation method thereof and use thereof
08/30/2012CA2828210A1 Preparation of bicyclic guanidine salts in an aqueous media
08/30/2012CA2827336A1 Flumazenil complexes, compositions comprising same and uses thereof
08/30/2012CA2825699A1 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
08/29/2012EP2492987A1 Organic electroluminescent element
08/29/2012EP2492317A2 Azo compound, azo pigment, dispersion containing the azo compound or azo pigment, coloring composition, ink for inkjet recording, ink tank for inkjet recording, inkjet recording method and recorded material
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2491042A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
08/29/2012EP2491041A2 Bivalent diazo bicyclic smac mimetics and the uses thereof
08/29/2012EP2491040A2 Method of preparing sitagliptin and intermediates used therein
08/29/2012EP2491039A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
08/29/2012EP2491038A1 Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
08/29/2012EP2491037A1 Compounds
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491032A1 Akt inhibitors
08/29/2012EP2491031A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491025A1 Azaazulene compounds
08/29/2012EP2491018A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
08/29/2012EP2490692A1 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/29/2012CN102086204B Industrialized production method of high-purity pemetrexed disodium
08/29/2012CN101687887B Tricyclic nitrogen containing compounds as antibacterial agents
08/29/2012CN101379041B Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
08/28/2012US8252814 Agents and crystals for improving excretory potency of urinary bladder
08/28/2012US8252804 Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same
08/28/2012US8252803 Piperidine derivatives
08/28/2012US8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors
08/28/2012US8252787 Protein kinase inhibitors
08/28/2012US8252784 Photoactivable nitrogen bases
08/28/2012US8252711 Self supporting structurally engineered non-platinum electrocatalyst for oxygen reduction in fuel cells
08/28/2012CA2711101C Fused heterocyclic derivatives and methods of use as c-met inhibitors
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/23/2012WO2012112708A1 Cytotoxic benzodiazepine derivatives and methods of preparation
08/23/2012WO2012112687A1 Methods of preparation of conjugates
08/23/2012WO2012111027A2 Process for pemetrexed disodium
08/23/2012WO2012111020A1 Pyrrolo [2,1-c]1,4]naphthodiazepine linked piperazine compounds and a process for the preparation thereof
08/23/2012WO2012110840A1 Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof
08/23/2012WO2012110554A1 Process for preparing silica particles containing a phthalocyanine derivative by microwave irradiation, said particles and uses thereof
08/23/2012WO2012110441A1 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders
08/23/2012WO2012110440A1 6 - cyclobutyl - 1, 5 - dihydro - pyrazolo [3, 4-d] pyrimidin- 4 - one derivatives their use as pde9a inhibitors
08/23/2012WO2012109747A1 Organic semiconducting compounds and devices generated therefrom
08/23/2012US20120214997 Method of preparing sitagliptin and intermediates used therein
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/23/2012US20120214826 Inhibitors of bruton's tyrosine kinase
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120214804 Pharmaceutical composition comprising indole compound
08/23/2012US20120214795 Fused heterocyclic ring derivative and use thereof
08/23/2012US20120214791 Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders
08/23/2012US20120214787 Oxadiazole inhibitors of leukotriene production
08/23/2012US20120214780 Substituted porphyrins
08/23/2012US20120214762 6,5-heterocyclic propargylic alcohol compounds and uses therefor
08/23/2012DE102011011539A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices
08/23/2012CA2827261A1 6-cyclobutyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
08/23/2012CA2825919A1 Methods of preparation of conjugates
08/22/2012EP2489668A1 Tetraazapyrene compounds and their use as n-type semiconductors
08/22/2012EP2489667A1 Quinoxaline derivative
08/22/2012EP2488532A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488528A1 Pyrrolo [3,2 -e][1,2,4]triazolo [1,5-a]pyrimidines derivatives as inhibitors of microglia activation
08/22/2012EP2488527A1 Pyrrolo [3, 2 -e][1,2,4]triazolo [1,5 -a]pyrimidines derivatives as inhibitors of microglia activation
08/22/2012EP2488526A1 Compounds for the treatment of hepatitis c
08/22/2012EP2488525A2 Antimicrobial compounds and methods of making and using the same
08/22/2012EP2488524A1 Pyrrolo[2,3-d]pyrimidine compounds
08/22/2012EP2488523A1 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012EP2488519A1 Pyrazolopyridine derivatives as anticancer agent
08/22/2012EP2488503A1 Amino - pyrimidine compounds as inhibitors of tbkl and/or ikk epsilon
08/22/2012EP1976836B1 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
08/22/2012EP1940838B1 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
08/22/2012EP1791816B1 Iodine-phenyl-substituted cyclic cetoenols
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012EP1401829B1 Novel heterocyclic antibacterial compounds
08/22/2012CN102648202A 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
08/22/2012CN102648201A N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
08/22/2012CN102648182A Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
08/22/2012CN102643765A Streptomyces, anti-tumor compound (Spiro-Indimycin A-D) as well as preparation method and application thereof
08/22/2012CN102643280A Folic-acid-modified phthalocyanino-silicon, and preparation method and application thereof
08/22/2012CN102643279A Synthesis method of allopurinol
08/22/2012CN102643278A Pyrrolo[2,3-d]pyrimidine derivative and application in preparation of anti-malignant tumor medicament thereof
08/22/2012CN102146081B Indoleacetic acid derivatives and preparation method and application thereof
08/22/2012CN101723900B Cinnamide compound
08/22/2012CN101535251B Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247413 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity
08/21/2012US8247409 Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
08/21/2012US8247392 Materials for selective trapping of carbon monoxide
08/21/2012CA2689429C Bicycloaniline derivatives
08/21/2012CA2616196C A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor
08/21/2012CA2552319C Hcv ns-3 serine protease inhibitors
08/16/2012WO2012109011A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/16/2012WO2012108490A1 Isoquinoline amide derivative
08/16/2012WO2012107934A1 Flinderole analogues and process for synthesis thereof
08/16/2012WO2012107500A1 [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
08/16/2012WO2012107465A1 Heterocyclic compounds as pi3 kinase inhibitors
08/16/2012WO2012088266A3 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/16/2012WO2012061342A3 Substituted benzo-imidazo-pyrido-diazepine compounds
08/16/2012WO2011042389A3 Phenylpyri(mi)dinylazoles and their use as fungicides
08/16/2012WO2008144483A3 Agents for treating disorders involving modulation of ryanodine receptors
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 573